Medication review and deprescribing in different healthcare settings: a position statement from an Italian scientific consortium
Italian consortium (SIGG et al.) · 2024 · Italy
Source and licence
- Authors
- Massimo Carollo, Virginia Boccardi, Salvatore Crisafulli et al.
- Title
- Medication review and deprescribing in different healthcare settings: a position statement from an Italian scientific consortium
- Journal
- Aging Clinical and Experimental Research, 2024
- Licence
- CC BY 4.0
- Changes
- Verbatim excerpts; formatting adapted
Full text retrieved 2026-10-27 from Europe PMC · PMC10923734
Licence statement of the original publication
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
This page reproduces excerpts of the original publication; the original is authoritative. It has not been reviewed by a physician, does not state a recommendation of Medelix and does not replace medical advice. The guideline may have been updated since.
Open the original publication →Full text on Europe PMC
Recommendations
We found no explicitly labelled recommendations in this publication; its recommendations are in the running text of the original.
Abstract
Recent medical advancements have increased life expectancy, leading to a surge in patients affected by multiple chronic diseases and consequent polypharmacy, especially among older adults. This scenario increases the risk of drug interactions and adverse drug reactions, highlighting the need for medication review and deprescribing to reduce inappropriate medications and optimize therapeutic regimens, with the ultimate goal to improving patients’ health and quality of life. This position statement from the Italian Scientific Consortium on medication review and deprescribing aims to describe key elements, strategies, tools, timing, and healthcare professionals to be involved, for the implementation of medication review and deprescribing in different healthcare settings (i.e., primary care, hospital, long-term care facilities, and palliative care). Challenges and potential solutions for the implementation of medication review and deprescribing are also discussed.
Contents of the original publication
The section headings of the original.
- Introduction
- Aim
- Target population
- Methodology of medication review and deprescribing
- Pharmacotherapeutic history
- Pharmacotherapeutic analysis
- Multidisciplinary pharmacotherapeutic plan
- Follow-up
- Aspects that are specific for different healthcare settings
- Primary care
- Hospitals
- Long-term care facilities and community hospitals
- Palliative care
- Challenges and potential solutions for the implementation of medication review and deprescribing
- Evaluation of the impact of medication review and deprescribing
- Conclusions
A question about this guideline?
Medelix answers clinical questions from guidelines and studies – every statement with its source.
Are you the rights holder and object to this reproduction? Write to contact@medelix.ai and we will take the page down promptly. Imprint